A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum AdjuvantJoanne M. Langley, Ilse Dieussaert, Walthère Dewé et al.|The Journal of Infectious Diseases|2016Cited by 67
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trialKathleen M. Mullane, P Chilingirov, Vicki A. Morrison et al.|The Lancet Infectious Diseases|2019Cited by 36
8th Canadian Immunization Conference Sheraton Centre Hotel, Toronto, Ontario November 30 to December 3, 2008J Bettinger, Louise Valiquette, David W. Scheifele et al.|Europe PMC (PubMed Central)|2008Cited by 0